Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an ...

Veterans working at the Nevada Test and Training Range can’t prove they were there due to their classified work, leaving them ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $10 million, before deducting the placement agent’s fees and other offering expenses payable by the ...

Incorporating sustainable practices in flooring selection, including optimizing concrete mixes and reducing the carbon ...

Lexaria, a global innovator in drug delivery platforms, expects to submit its IND application for its planned U.S. Phase 1b Hyperten ...

As the market sees increasing signs of a softening market, thoughts for 2025 are likely to turn to maintaining the bottom ...

the preliminary nature of metallurgical test results; the Company’s ability to restart and develop the Bunker Hill Mine and the risks of not basing a production decision on a feasibility study of ...